Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Open accessThe DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index.
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for steatotic liver disease associated with metabolic syndrome. MASLD is the most common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality. It is important that all stakeholders be involved in tackling the public health threat of obesity and obesity-related diseases, including MASLD. A simple and clear assessment and referral pathway using non-invasive tests is essential to ensure that patients with severe MASLD are identified and referred to specialist care, while patients with less severe disease remain in primary care, where they are best managed. While lifestyle intervention is the cornerstone of the management of patients with MASLD, cardiovascular disease risk must be properly assessed and managed because cardiovascular disease is the leading cause of mortality. No pharmacological agent has been approved for the treatment of MASLD, but novel anti-hyperglycemic drugs appear to have benefit. Medications used for the treatment of diabetes and other metabolic conditions may need to be adjusted as liver disease progresses to cirrhosis, especially decompensated cirrhosis. Based on non-invasive tests, the concepts of compensated advanced chronic liver disease and clinically significant portal hypertension provide a practical approach to stratifying patients according to the risk of liver-related complications and can help manage such patients. Finally, prevention and management of sarcopenia should be considered in the management of patients with MASLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The growing yearly prevalence of Metabolic Dysfunction–non-alcoholic fatty liver disease (MASLD) has emerged as a worldwide public health concern, driven by improved living conditions, evolving lifestyle habits, and the widespread occurrence of obesity, diabetes, and metabolic syndrome.1”
From The Impact of Omega-3 Fatty Acids on Triglyceride Levels in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis of Randomized Controlled Trials with Subgroup Analysis by Diabetes Status (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is because the clinical definition of MASLD, as previously noted, includes not only the presence of steatosis but also a cardiometabolic context [31,32,33], which cannot be fully reproduced in a monoculture of hepatocyte-like cells.”
From The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease (2026) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 2×
“102 Of late, there is a growing interest in studies on the association between sarcopenia and MASLD.”
BackgroundEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Cited by
Items 401–500 of 784
What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development?
Pan, Q., Xu, Q.-Y., Zhang, L.-H., & He, Y. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i5.97500 · Cited by 4
Zhaivoronok, M., Dynnyk, O., Livkutnyk, O., Yerokhovych, V., Yuzvenko, V., Serednia, I., Melnychenko, Y., & Kobyliak, N. M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1457960 · Cited by 2
Song, K., Kwon, Y., Lee, E. J., Lee, H. S., Youn, Y. H., Baik, S. J., Lee, H., Kim, J. Y., Choi, Y., & Chae, H. W. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-03880-z · Cited by 2
Kalam, F., Ansu, V., Akasheh, R. T., & Jovanovic, C. E. S. (2025) · Academia Nutrition and Dietetics · doi:10.20935/acadnutr7669 · Cited by 3
Wu, J., Cui, S., Li, X., Zhang, X., Yang, S., Sun, J., & Jiang, X. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1540357 · Cited by 3
Wu, M., Li, Y., Liu, D., Wen, W., Yan, M., Su, Q., An, Z., & Yang, X. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02631-3 · Cited by 4
Glenn, A. O., Green, S., Mouzaki, M., & Trout, A. T. (2025) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70142 · Cited by 2
Ma, Z., Chen, M., Cao, Y., Song, D., & Zhang, L. R. (2025) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073379080250701164923 · Cited by 2
Park, J., Kim, J. W., & Lim, S. (2025) · Annals of Nutrition and Metabolism · doi:10.1159/000547347 · Cited by 4
Yang, S., Zhang, L., Hu, M., & He, W. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1637572 · Cited by 3
Kim, M. J., Park, Y. R., Jang, G., Han, Y. K., Ishii, I., Jang, S. Y., & Park, K. M. (2025) · Antioxidants and Redox Signaling · doi:10.1177/15230864251377735 · Cited by 3
Metabolic Dysfunction Associated to Steatotic Liver Disease: A Review
Torres, J. V. D., Guerrero, V. R. V., Gómez, J. P. V., Miranda, F. J. P., Álvarez, L. R. O., Insignares, J. D. L., Mares, M., Ortiz, H. M. R., & Mendoza‐Torres, E. (2025) · Metabolic Syndrome and Related Disorders · doi:10.1177/15578518251382048 · Cited by 4
Oyama, M., Namisaki, T., Shibamoto, A., Iwai, S., Takami, M., Tsuji, Y., Fujinaga, Y., Takaya, H., Inoue, T., Nishimura, N., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199560 · Cited by 2
Kasar, A., Boateng, S., Ameyaw, P. A., Issaka, Y., Al‐Ajlouni, Y. A., Balasundaram, R. B., & Njei, B. M. (2025) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2025.2563490 · Cited by 2
“Dairy-rich diets: A promising strategy for reducing the risk of metabolic liver disease”
Ahsan, M. U., Fatima, A., Maryam, A., & Asmat, K. N. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.11.003 · Cited by 2
What Is in a Name: Understanding the Nomenclature Updates for Fatty Liver Disease
Fowler, K. J., & Chernyak, V. (2024) · Radiology · doi:10.1148/radiol.232771 · Cited by 2
Baumert, B. O., Maretti-Mira, A. C., Li, Z., Stratakis, N., Zhao, Y., Walker, D. I., Wang, H., Fischer, F. C., Jia, Q., Valvi, D., et al. (2024) · medRxiv · doi:10.1101/2024.07.01.24309775 · Cited by 2
Selecting Preclinical Animal Models in Hepatology Research: A Call for Uniform Guidelines
Ezhilarasan, D., & Najimi, M. (2024) · Laboratory Investigation · doi:10.1016/j.labinv.2024.102179 · Cited by 3
Ha, Y.-S., Kim, W. K., & Kim, S. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2025.0036 · Cited by 2
Decoding MASLD Progression: A Molecular Trajectory-Based Framework for Modelling Disease DynamicsPreprint
Kamzolas, I., Koutsandreas, T., Barker, C. G., Pournara, A. V., Weston, H., Fujiwara, N., Hoshida, Y., Anstee, Q. M., Vacca, M., Papatheodorou, I., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.14.632908 · Cited by 2
Zhang, S., Liang, H., Liu, J., & Zhu, Y. (2025) · Research Square · doi:10.21203/rs.3.rs-6867840/v1 · Cited by 2
Li, H., & Li, T. (2026) · Frontiers in nutrition · doi:10.3389/fnut.2026.1833688 · Cited by 1
Karas, D. R., Juszli, S., Walston, M., Love, A., & Bigham, M. T. (2024) · Pediatric Quality and Safety · doi:10.1097/pq9.0000000000000747 · Cited by 3
de Boom, F., Talib, A., Roebroek, Y. G. M., Paulus, G. F., Koek, G. H., Robben, S. G. F., Winkens, B., Bouvy, N. D., & van Heurn, E. L. W. (2024) · Children · doi:10.3390/children11080965 · Cited by 5
Lakhdhir, F., Muhammad, A. S., Qureshi, A. N., Shaikh, I. A., Joher, I., Majeed, J., & Khan, J. A. (2024) · Cureus · doi:10.7759/cureus.71639 · Cited by 2
Hagenstein, L. D., Jenkins, J., Adamson, C., Dong, J., Moore, J. H., & Gao, J. (2024) · Clinical Imaging · doi:10.1016/j.clinimag.2024.110326 · Cited by 1
ElGhandour, A. M., Teama, N. M., Kamal, M. A., Nashaat, E. H., Ghani, A. M. A., & Abdo, A. A. (2024) · Egyptian Liver Journal · doi:10.1186/s43066-024-00387-8 · Cited by 1
Basham, A., Rafati, S., Teshnizi, S. H., Evazi, E., Khozeimeh, F., Alavian, S. M., & Razmpour, F. (2024) · Hepatitis Monthly · doi:10.5812/hepatmon-150455 · Cited by 1
Joly, A., Thoumas, J., Lambert, A., Caillon, E., Leulier, F., & Vadder, F. D. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00879-9 · Cited by 1
Liu, A., Sun, Y., Qi, X., Zhou, Y., Zhou, J. W., Li, Z., Wu, X., Zou, Z., Lv, X., Li, H., et al. (2025) · Endocrine · doi:10.1007/s12020-025-04168-0 · Cited by 2
Taheri, E., Ehtesham, H., Safdari, R., & Hormati, A. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01606-8 · Cited by 1
Iwasaki, W., Soma, H., Yamazaki, H., Zhang, B., Fukami, Y., Tanaka, Y., Sato, M., Nishimukai, M., & Ishizuka, S. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100095 · Cited by 1
El-sheikh, H. M., El-Haggar, S. M., Badawi, R., & Habba, E. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177735 · Cited by 1
Transcriptome Analysis Revealed the Therapeutic Effect of Scutellarin on MASLD
Wang, J., Yang, M., Cui, E., Li, S., & Fan, X. (2025) · ACS Omega · doi:10.1021/acsomega.4c09465 · Cited by 2
Ma, Z., Wang, B., Li, D., & Chen, X. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70087 · Cited by 1
Nyamsuren, U., Peng, Y., & Shin, S. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70132 · Cited by 1
Lichtler, R., Klossner, H., Smith, N., Hoyo, C., & Cowley, M. (2025) · FASEB BioAdvances · doi:10.1096/fba.2025-00045 · Cited by 1
Zhang, X., & Nguyen, M. H. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156350 · Cited by 1
Emerging vesicular nanosystems capable of effectively targeting hepatocytes
Chan, V., Pierre, A. S., Đỗ, T. H., & Li, S. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2534326 · Cited by 2
Armes, S., Tibaes, J., Rajaram, R., Ruddock, M. W., Kurth, M. J., FitzGerald, P. S., Golubić, R., & Ray, S. (2025) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2025-001236 · Cited by 4
Self-citationLiu, X., Ma, Y., Xu, Z., & Wang, J. (2025) · Journal of Food Biochemistry · doi:10.1155/jfbc/7436788 · Cited by 1
Cai, J., Wang, W., Lin, D.-L., Ren, S.-F., Jia, Q.-Q., He, X.-X., Yang, X., Cai, W., & Hou, H. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s525751 · Cited by 2
Gloor, D. A., Todorski, I., Peters, A. A., Wagner, B., Gassenmaier, T., Roos, J. E., Christe, A., Ebner, L., & Huber, A. T. (2025) · European Radiology · doi:10.1007/s00330-025-11886-6 · Cited by 1
Pyo, J. H., Cho, S. J., Jee, J., Park, G., Ahn, J., Kim, K., Kang, M., Rónaszéki, A., Kaposi, P. N., Damato, E., et al. (2025) · Journal of Clinical Ultrasound · doi:10.1002/jcu.70024 · Cited by 1
Joubert, M. B. V., Oliva, M. E., Ingaramo, P. I., & D’Alessandro, M. E. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112643 · Cited by 2
Raissa, N. J., Yao, S.-Y., & Wang, F. W. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i33.110176 · Cited by 1
Luo, L., Shao, C., Dong, Z., Zhuo, S., Feng, S., Wang, W., Ye, J., & Zhong, B. (2025) · Biomedicines · doi:10.3390/biomedicines13092161 · Cited by 3
Kanagaddi, R., Nannapaneni, S. S., Katari, N. K., Salakolusu, S., & Murty, J. N. S. R. C. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.115264 · Cited by 2
Rotolo, O., Bonfiglio, C., Reddavide, R., Cisternino, A. M., Inguaggiato, R., & Giannelli, G. (2025) · Nutrients · doi:10.3390/nu17172905 · Cited by 1
Berg, E. V., Moftah, S., Yuzbashian, E., & Chan, C. B. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.09.020 · Cited by 1
Metabolic Dysfunction-Associated Steatotic Liver Disease in a Patient with Phelan–McDermid Syndrome
Boccuto, L., Scarlata, G. G. M., Moffitt, B. A., Sarasua, S. M., Phelan, K., Rogers, C. R., & Abenavoli, L. (2025) · Life · doi:10.3390/life15101586 · Cited by 1
Xu, S., Xiao, Y., Xu, C., Zeng, X., Zhao, L., Li, T., Jiang, D., Na, R., & Chen, H. (2025) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2025-002702 · Cited by 1
Zhang, J., & Shi, H. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02741-0 · Cited by 2
Impact of preoperative liver disease diagnosis on postoperative outcomes in bariatric surgery
Teklu, Y., Corpodean, F., Kachmar, M., Schauer, P. R., Cook, M. W., & Albaugh, V. L. (2025) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2025.10.006 · Cited by 1
Khaing, W., Nyamsuren, U., & Shin, S. (2025) · Nutrition Research · doi:10.1016/j.nutres.2025.10.008 · Cited by 1
Osan, J. K., Rakoczy, S. G., Pecoraro, H. L., & Brown‐Borg, H. M. (2025) · GeroScience · doi:10.1007/s11357-025-02017-6 · Cited by 1
Cheng, C., Yang, R., Chen, W.-T., Chung, J.-F., & Ku, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411877 · Cited by 1
Semi-Supervised Fatty Liver Classification Using Attention-Based Graph Neural Network Models
Kim, S. Y., Wang, S., Sohn, K.-A., & Choe, E. K. (2025) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e30 · Cited by 1
Sedibe, A., Sibiya, N., Nyakudya, T., & Gamede, M. W. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102345 · Cited by 3
Chandrasekharnath, N., Uma, A., & Mahalakshmi, Y. V. (2025) · Comparative Clinical Pathology · doi:10.1007/s00580-025-03732-4 · Cited by 1
Hang, Q., Xu, T., Guo, J., Li, R., Zhao, K., Guo, Y., Shao, L., Zhu, H., Xu, Q., & Ji, M. (2025) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2025.100427 · Cited by 1
Pandovski, S., Yang, T., Zhou, H. H., Rosahl, T. W., Carballo‐Jane, E., Talukdar, S., & Coyne, E. S. (2026) · Biochemical Journal · doi:10.1042/bcj20253411 · Cited by 2
Bisphenol F and Steatotic Liver Disease: Resolving the PXR Paradox Through Stress Pathway Mechanisms
AbdalHussin, E. A., Hamid, Z. A., Idris, M. H. M., Omar, M. H., & Taib, I. S. (2025) · Biomedicines · doi:10.3390/biomedicines14010030 · Cited by 1
Hatab, A., Mansour, N. G., Rabha, A., & Abouhatab, R. (2025) · Cureus · doi:10.7759/cureus.100043 · Cited by 1
MASLD or MetALD? Unveiling the Role of Alcohol in Liver Disease Progression in Diabetic Patients
Stratina, E., Stanciu, C., Năstasă, R., Zenovia, S., Stafie, R., Rotaru, A., Chiriac, S. A., Gîrleanu, I., Muzica, C. M., Minea, H. O., et al. (2025) · Biomedicines · doi:10.3390/biomedicines14010082 · Cited by 1
Mahajan, S., Narendrakumar, L., Dhiman, P., Gupta, M., Mudgal, P., Yadav, R., Arava, S., Bhatnagar, S., Wadhwa, N., Kumar, Y., et al. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-025-01207-w · Cited by 3
Masrour, O., Morvan, J., Rapin, A., Aimé, A., Burel, A., Genêt, V., Brisset, S., Lagadic‐Gossmann, D., Bardou‐Jacquet, E., & Martin‐Chouly, C. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.12.003 · Cited by 2
Extracardiac imaging biomarkers of cardiovascular health: a comprehensive review
Ahn, W. J., Choi, I. Y., Shim, E., Yeom, S. K., Hwang, S. H., Yong, H. S., Lee, Y. H., & Kim, C. (2026) · British Journal of Radiology · doi:10.1093/bjr/tqag006 · Cited by 2
Global Bivariate Meta‐Analysis of FIB‐4 Cut‐Offs to Rule Out Advanced Fibrosis in MASLD
Ghosal, A., & Ghosal, S. (2026) · International Journal of Hepatology · doi:10.1155/ijh/9419416 · Cited by 1
Fueling Disease: ACSS2 in Obesity‐Associated Metabolic Disorders and Cancer Progression
Chen, L., Wang, Y., & Yang, J. (2026) · Obesity Reviews · doi:10.1111/obr.70096 · Cited by 1
Schwartz, A. W., Park, E. Y., Ilagan‐Ying, Y. C., Zimmerman, Z., Bollinger, B., Ying, L., Deng, Y., Duffy, A. J., Morton, J. M., Mehal, W. Z., et al. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i1.113753 · Cited by 1
Ogbu, C. E., Goel, A., Gupta, A., Doad, J. S., Oparanma, C. O., Ezechukwu, M., Umerah, C., & Barritt, A. S. (2026) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000975 · Cited by 1
Rashid, S. A., Suriyan, A., Azam, M. B., Balasubramanian, R., Maideen, N. M. P., Chidambaram, K., & Amirthalingam, P. (2026) · Hormone and Metabolic Research · doi:10.1055/a-2787-1205 · Cited by 1
Inflammaging in geriatric liver disease: Mechanistic insights and therapeutic frontiers
Xu, X., Wei, X., Yang, X., & Lin, S. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112165 · Cited by 2
Ni, Z., Wang, R., Miao, H., Wang, G., Lim, W. L. F., Zhang, S., Lam, S. M., & Shui, G. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.02.067 · Cited by 1
Mohamed, M. A., Taha, M. M. M. I., & Ibrahim, M. M. M. R. (2026) · ASIDE Gastroenterology · doi:10.71079/aside.gi.022626448 · Cited by 2
Choline and DNA methylation: impact across metabolic, oncogenic and neurodevelopmental disorders
Sareen, S., Bakovic, M., & Cho, C. E. (2026) · Clinical Epigenetics · doi:10.1186/s13148-026-02086-0 · Cited by 4
Vargas, M., Ferreira, M. D. R., Ingaramo, P. I., Collins, P., & D’Alessandro, M. E. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1781406 · Cited by 2
Personal income perception and the risk of metabolic dysfunction-associated steatotic liver disease
Casimo, G., Donghia, R., Tatoli, R., Bonfiglio, C., & Giannelli, G. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1739165 · Cited by 1
Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Wang, R., Liu, Z., Lin, J., Zhang, W., Liu, X., & Zhang, T. (2026) · Portal hypertension & cirrhosis · doi:10.1002/poh2.70043 · Cited by 2
Basil, B. (2026) · Frontiers in Epidemiology · doi:10.3389/fepid.2026.1765215 · Cited by 1
Bilirubin Ameliorates Oleic and Palmitic Acid Accumulation in an In Vitro Model of MASLD
Pospíšilová, K., Tulachova, N., Onhajzer, J., Dvořák, A., & Vítek, L. (2026) · Physiological Research · doi:10.33549/physiolres.935696 · Cited by 1
Machado, E. D. A., Themístocles, B. L. C., Teixeira, J. M. R., Jannuzzi, F. M. G., Tomaz, G., Oliveira, C. L., Madeira, I. R., Terra, C., Souza, M. D. G. C., Monteiro, A., et al. (2026) · Jornal de Pediatria · doi:10.1016/j.jped.2026.101534 · Cited by 1
CT-assessed abdominal visceral adiposity and MASLD: a sex-stratified cross-sectional analysis
Xu, L., Chen, T., Xie, Y., Xiang, X., Liu, Y., Xu, C., & Wang, S. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1750470 · Cited by 1
Mapouka, M., Pabingui, E., Tazinkeng, N., Gurmessa, M., Vickos, U., Ndemazie, N. B., & Police, S. M. C. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i13.114657 · Cited by 2
Li, Y., Zhao, C., Wang, J., & Shi, T. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1708671 · Cited by 1
Abdulla, A. H., Sheikhnoor, A., Ferrao, K., Stiles, L. I., & Mehta, K. J. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02102-w · Cited by 3
Gu, Y.-H., Yuan, K., Zhang, L.-B., Xiong, J., Xie, N., Li, T.-Z., Rong, S., & Yuan, B. (2026) · Environmental Chemistry and Ecotoxicology · doi:10.1016/j.enceco.2026.04.005 · Cited by 1
Solmaz, İ., Kırık, A., Demir, İ., Dizdar, O. S., Gözel, N., Tazegül, G., Başgöz, B. B., Şahin, C., Issever, K., Aktaş, G., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-45869-4 · Cited by 1
Xue, L., Wang, X., & Mao, J. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1808135 · Cited by 1
A TyG–UHR-based machine learning model for screening lean MAFLD: development and external validation
Ji, Y., Zhang, H., Xia, J., Chen, G., & Li, H. (2026) · BioMedical Engineering OnLine · doi:10.1186/s12938-026-01585-8 · Cited by 1
Zhang, H., Hu, Y., Cai, J., Zhang, N., Zhang, Y., Xiang, Y., Zhong, J., Meng, Q., Tan, Q., Gao, X., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70851 · Cited by 1
Котлярова, А. А., & Kotlyarov, S. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104453 · Cited by 1
Zhou, X., Xu, H., Wang, H., Zhang, H., Chen, Y., & Chen, J. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121891 · Cited by 3
Ye, L., Le, J., Lei, X., Song, F., Guo, Y., Gao, J., & Liu, Y. (2026) · Biomolecules · doi:10.3390/biom16050751 · Cited by 1
Won, J.-H., Baek, K., Xiang, Y.-Y., & Kim, J. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00568.2025 · Cited by 1
Nair, B., Gopalakrishna, R., & Nath, L. R. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i5.115659 · Cited by 1
Alghzawi, H. M., Sahu, S., Rana, A., Mwita, R. P., Gundapaneni, S. R. C., & Dahiya, D. (2026) · Abdominal Radiology · doi:10.1007/s00261-026-05573-3 · Cited by 1
Jain, V. S., Vong, T., Thompson, V. L., Lopez-Silva, C., Sequeira, L., Rizer, N. W., Hinson, J. S., Klein, E., Copenhaver, M. S., Brookmeyer, C., et al. (2026) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2026.05.035 · Cited by 1
Metadata
- Authors
- Chan, W.-K., Chuah, K.-H., Rajaram, R. B., Lim, L.-L., Ratnasingam, J., & Vethakkan, S. R.
- Affiliations
- University of Malaya (MY)
- Chinese University of Hong Kong (HK)
- Corresponding author
- Chan, Wah-Kheong
- Venue
- Journal of Obesity & Metabolic Syndrome
- Published
- 2023-09-13
- Volume
- 32
- Issue
- 3
- Pages
- 197-213
- ISSN
- 2508-6235 (ISSN-L)
- 2508-7576
- PMC
- PMC10583766
- OpenAlex
- W4386704735
- Cited by
- 776
- References
- 122
- Citations by year
- 2026: 245 · 2025: 342 · 2024: 183 · 2023: 5
- FWCI
- 30.29
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
- Locations
- Journal of Obesity & Metabolic Syndrome (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, metabolic syndrome, obesity, chronic liver disease, non-invasive liver assessment, referral pathways, lifestyle intervention, cardiovascular risk, anti-hyperglycemic drugs, liver cirrhosis, decompensated cirrhosis, compensated advanced chronic liver disease, clinically significant portal hypertension, sarcopenia, liver complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.